LUCIUS 卢修斯舒尼替尼 Sunitinib 胃肠道间质瘤 晚期肾细胞癌 胰腺神经内分泌肿瘤

舒尼替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Sunitinib

老挝国家食药监局批准上市
老挝国家药检所检测认证
胃肠道间质瘤

Each capsole contains Sunitimib malate 33.42 mg

eguralent to sunitinik

Isdicatie:

LUCIUS

晚期肾细胞癌

LaciSuniis a kinase intibitor indicated for the treztmert
Cistrons sionial tumor (GiST) after disees

PHARMACEUTICALS

roecssaaoil or intolerance to imatinib mesvlate
Advanced renal cell carcinoma (RCC)

e treatment of

*Frogressive, vell-anterentiated pa

LuciSuni

胰腺神经内分泌肿瘤

uresectable focallu adusncad or matostotl Aea
Desage and Use:
ced or metastatic dis2ase.
GIST andRCC.
50 mg orlly once daily, with or without food, 4 weeks
on freatment follon ed br 2 weeks off.
DNET:

Sunitinib Capsules

.37.5 mg orally once danty. witn or without food,
centinoously withort a scheda led off-treatnent peraod
Dase Modification:

25mg

* Dose interruptions and or dose adjustsests of 12.5 mg
tecortterded based on indi vidual safety and tolerabilit

FDA批准

Storage: in a dry place and store at 20C 1o25C
Warning:

Rx Only

Keep medicine out of reach of Children. De not administer
LaciSuni durina Preenaney and Lictation
PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by

LUCIUS

Thongmang village, Xaythany distric
Vientiane Capital, Laos

权威认证

Waraing: Tobe sold by retall on prescrpuo
ol registered physcians only, and as o
e piysacian.

28 Capsules

口碑质量

适应症。
1、治疗使用甲磺酸伊马替尼后病情进展或不耐受的胃肠道间质瘤(GIST)。
2、晚期肾细胞癌(RCC)。
3、患有无法切除的局部晚期或转移性疾病的进展性、分化良好的胰腺神

经内分泌肿瘤(pNET)。
推荐剂量:
1、GIST和RCC:每日口服一次,每次50mg,可与食物同服或单独服
用,治疗4周,然后停药2周。
2、pNET:每日口服一次,每次37.5mg,可与食物同服或单独服用,连
续服用,无预定的停药期。
3、剂量调整:根据个人安全性和耐受性,建议剂量中断和/或剂量调整
12.5mg.